儿童癌症患者金黄色葡萄球菌血流感染的并发症
这项多中心回顾性研究纳入2005至2022年322例儿童肿瘤患者金黄色葡萄球菌血流感染发作,评估并发症危险因素及中心静脉导管(CVC)移除与保留的影响。结果显示CVC保留与主要并发症独立相关(OR 3.37),支持对此人群移除导管的推荐。
要点
- 儿童肿瘤患者金黄色葡萄球菌血流感染中,CVC保留与更多短期和晚期并发症独立相关。
- 主要复合结局包括复发性血流感染、深部脓肿/肌炎、感染相关死亡、出口部位感染、脑膜炎、心内膜炎或骨髓炎。
- 甲氧西林耐药、男性、就诊时侵袭性感染、植入式输液港、脓毒症和持续血培养阳性亦与主要结局独立相关。
核心结论
- 在儿童肿瘤患者金黄色葡萄球菌血流感染中,CVC移除与较少的短期和晚期并发症相关,支持该人群移除导管的推荐。
研究设计与样本
- 多中心回顾性研究纳入2005至2022年儿童肿瘤患者金黄色葡萄球菌血流感染发作。
- 并发症结局期(初始阳性培养后72小时至6个月)分为短期(72小时至8天)和晚期(8天至6个月)。
- 采用倾向评分加权对CVC移除进行多变量逻辑回归分析。
主要发现
- 322次血流感染发作中,90.7%(292/322)就诊时带有CVC,其中55.5%(162/292)尝试保留导管。
- 带CVC的发作中主要结局发生率为21.2%(62/292),CVC保留组为25.3%(41/161),移除组为16.2%(21/130)。
- CVC保留与主要结局独立相关(OR 3.37;95%CI 2.08-5.61;P<.01),短期OR 21.8(95%CI 7.09-95.4),晚期OR 1.83(95%CI 1.06-3.18)。
- 甲氧西林耐药、男性、就诊时侵袭性感染、植入式输液港、脓毒症和持续血培养阳性亦与主要结局独立相关。
关键数值与推荐
- 主要复合结局定义为发生至少1项主要并发症:复发性血流感染、深部脓肿/肌炎、金黄色葡萄球菌相关死亡、出口部位感染、脑膜炎、心内膜炎或骨髓炎。
临床怎么用
- 对于儿童肿瘤患者金黄色葡萄球菌血流感染,考虑移除CVC以降低短期和晚期并发症风险。
- 评估甲氧西林耐药、男性、就诊时侵袭性感染、植入式输液港、脓毒症和持续血培养阳性等危险因素有助于识别高危患者。
局限性
- 本研究为回顾性设计,可能存在残余混杂。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Staphylococcus aureus bloodstream infections (BSIs) can cause significant morbidity in children with cancer. Current guidelines recommend central venous catheter (CVC) removal, though the necessity remains uncertain. We assessed risk factors for complications among affected patients, focusing on impact of CVC removal vs salvage. METHODS: This multicenter retrospective study includes pediatric oncology patients with S aureus BSIs from 2005 to 2022. The complication outcome period (72 hours to 6 months after initial positive culture) was divided into short-term (72 hours to 8 days) and late periods (8 days to 6 months). The composite primary outcome included occurrence of at least 1 major complication: recurrent BSIs, deep abscess/myositis, S aureus-related death, exit site infection, meningitis, endocarditis, or osteomyelitis. Multivariable logistic regression with propensity score weighting for CVC removal was performed. RESULTS: Among 322 BSI episodes, 90.7% (n = 292/322) had a CVC at presentation; salvage was attempted in 55.5% (n = 162/292). The primary outcome was met in 21.2% (n = 62/292) of episodes with a CVC, more frequently in the CVC salvage (25.3%, n = 41/161) vs removal (16.2%, n = 21/130) group. CVC salvage was independently associated with the primary outcome (OR, 3.37; 95% CI, 2.08-5.61; P < .01) in short-term (OR, 21.8; 95% CI, 7.09-95.4) and late (OR, 1.83; 95% CI, 1.06-3.18) periods. Methicillin resistance, male sex, invasive infection at presentation, implanted ports, sepsis, and persistent blood culture positivity were also independently associated with the primary outcome. CONCLUSIONS: CVC removal was associated with fewer short-term and late complications in pediatric cancer patients with S aureus BSIs, supporting recommendations for catheter removal in this population.
引用
- Slatnick LR, Giles J, Miller TP, et al. Complications in Pediatric Cancer Patients With Staphylococcus aureus Bloodstream Infection. Pediatrics. 2026. PMID: 42976932. doi:10.1542/peds.2025-075263
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。